Does MIRABEGRON Cause Product use in unapproved indication? 811 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 811 reports of Product use in unapproved indication have been filed in association with MIRABEGRON (MIRABEGRON). This represents 3.9% of all adverse event reports for MIRABEGRON.
811
Reports of Product use in unapproved indication with MIRABEGRON
3.9%
of all MIRABEGRON reports
489
Deaths
439
Hospitalizations
How Dangerous Is Product use in unapproved indication From MIRABEGRON?
Of the 811 reports, 489 (60.3%) resulted in death, 439 (54.1%) required hospitalization, and 418 (51.5%) were considered life-threatening.
Is Product use in unapproved indication Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MIRABEGRON. However, 811 reports have been filed with the FAERS database.
What Other Side Effects Does MIRABEGRON Cause?
Drug ineffective (4,151)
Off label use (1,704)
Intentional product misuse (1,416)
Dizziness (1,297)
Headache (1,288)
Blood pressure increased (1,100)
Hypertension (1,057)
Dry mouth (1,034)
Diarrhoea (921)
Pain (921)
What Other Drugs Cause Product use in unapproved indication?
DUPILUMAB (33,452)
DICLOFENAC (12,197)
METHOTREXATE (8,930)
PREDNISONE (7,625)
RITUXIMAB (7,519)
MYCOPHENOLATE MOFETIL (5,910)
ACETAMINOPHEN (5,819)
CYCLOPHOSPHAMIDE (5,750)
RISPERIDONE (5,551)
TACROLIMUS (5,057)
Which MIRABEGRON Alternatives Have Lower Product use in unapproved indication Risk?
MIRABEGRON vs MIRALAX
MIRABEGRON vs MIRCERA
MIRABEGRON vs MIRENA
MIRABEGRON vs MIRIKIZUMAB-MRKZ
MIRABEGRON vs MIRTAZAPINE